In Vitro Antimicrobial Activity of MSI-78, a Magainin Analog

AUTOR(ES)

Fuchs, Peter C.

FONTE

American Society for Microbiology

RESUMO

MSI-78 is a cationic peptide with broad-spectrum antimicrobial activity and is being developed as a topical agent. We compared the in vitro activity of MSI-78 with those of ofloxacin and other antibiotics against fresh clinical isolates. Based on MIC distribution statistics, strains for which the MSI-78 MIC was ≤64 μg/ml were assumed to be susceptible for purposes of this report. Of 411 aerobic isolates tested, 91% were susceptible to MSI-78, compared to 91% for ofloxacin and 92% for ciprofloxacin. Only enterococci consistently required ≥64 μg of MSI-78/ml for inhibition. MSI-78 demonstrated bactericidal activity equivalent to that of ofloxacin. Of 61 anaerobes, 97% were susceptible to MSI-78. Of 10 isolates of Candida albicans, 3 were inhibited by MSI-78 at 24 h. Further studies of this compound appear to be warranted.

Documentos Relacionados

• In Vitro Antibacterial Properties of Pexiganan, an Analog of Magainin
• Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo.
• Antimicrobial activity of synthetic magainin peptides and several analogues.
• Cetocycline, Tetracycline Analog: In Vitro Studies of Antimicrobial Activity, Serum Binding, Lipid Solubility, and Uptake by Bacteria
• In Vitro Antimalarial Activity of a New Organometallic Analog, Ferrocene-Chloroquine